Table 2.
Details of radiotherapy
| Overall treatment time (days) | |
| Median (range) | 48 (36–74) |
| EBRT | |
| Dose to central pelvis (Gy) | |
| Median (range) | 40 (20–56) |
| Dose to parametrium and pelvic wall (Gy) | |
| Median (range) | 50 (39.6–56) |
| IGBT | |
| Total dose prescribed at point A (Gy) | |
| Median (range) | 18 (12–24) |
| Total EQD2 (α/β = 10) at point A (Gy) | |
| Median (range) | 24 (14–32) |
| Total EQD2 (α/β = 10) of HR-CTV D90 (Gy) | |
| Median (range) | 31 (5–55) |
| Volume of HR-CTV at 1st IGBT (ml) | |
| Median (range) | 28 (10–128) |
| Distance from tandem axis to A/P edge of the HR-CTV (mm) | |
| Median (range) | 20 (10–44) |
| Distance from tandem axis to lateral edge of the HR-CTV (mm) | |
| Median (range) | 22 (14–39) |
| EBRT + IGBT | |
| Total EQD2 at point A (Gy) | |
| Median (range) | 64 (52–80) |
| Total EQD2 of HR-CTV D90 (Gy) | |
| Median (range) | 72 (55–95) |
EBRT = external beam radiotherapy, IGBT = image-guided intracavitary brachytherapy, EQD2 = the equivalent dose in 2 Gy fractions, HR-CTV = high-risk clinical target volume.